Lyophilization raises a handful of sensible questions. This page answers them in order, starting with the fundamentals and moving to applications.
Reviewed 2026-05-01. Anything still debated is marked as such rather than presented as settled.
The most frequently cited identity is a seven-residue fragment with the sequence LKKTETQ, taken from the actin-binding domain of the parent protein. A separate molecule, N-acetyl-seryl-aspartyl-lysyl-proline, often shortened to Ac-SDKP, derives from the same protein's N-terminal region and appears in overlapping literature. Reported molecular masses therefore differ between sources, and a mass value on its own does not establish which fragment is present. Confirmation requires a defined sequence rather than a single number.
Research interest in thymosin beta-4 fragments centres on actin sequestration, cell migration and tissue repair models. Most published work uses cultured cells or animal wound and cardiac preparations, and findings are generally described as preliminary. No fragment of this protein has been approved as a therapeutic product by major regulators. Reviews of the field note inconsistent dosing, delivery routes and outcome measures across studies, which complicates direct comparison. The material is best understood as a laboratory reagent with an active but unresolved research literature.
Discussion of TB-500 appears in several distinct literatures that rarely cite one another. Peer-reviewed studies usually describe in vitro assays or small animal experiments and are cautious about extrapolation. Veterinary and sports communities circulate anecdotal reports with limited methodological detail. Commercial listings add a third layer, often using the name interchangeably with thymosin beta-4 even though the two molecules differ in size and sequence. Regulatory status varies by country, and the compound is not a licensed medicine in most jurisdictions, so readers comparing sources should check which molecule and which purity each source actually describes.
TB-500 is a synthetic seven-residue peptide whose sequence, LKKTETQ, matches the N-terminal actin-binding region of thymosin beta-4. It is usually supplied in an N-terminally acetylated form, a modification that blocks the free amino terminus and can influence behavior in solution. In the research literature the same sequence appears under several names, including thymosin beta-4 fragment and shortened thymosin beta-4. Because it is a short peptide rather than the full 43-residue parent protein, its measured properties differ from those reported for thymosin beta-4 as a whole, and the two are not interchangeable in experimental design.
| Property | Value | Notes |
|---|---|---|
| Appearance | White to off-white lyophilized powder | Typical form for short synthetic peptides |
| Solubility class | Freely soluble in water and aqueous buffer | Dissolution aided by gentle mixing, not vigorous shaking |
| Typical storage temperature | −20 °C, desiccated | −80 °C used for long-term holding |
| Common analytical method | Reverse-phase HPLC with UV detection near 214 nm | Identity confirmed separately by mass spectrometry |
| Common synonyms | Thymosin beta-4 fragment; TB4 fragment | Naming varies between suppliers and publications |
The regulatory position is broadly consistent across major jurisdictions: no thymosin beta-4 fragment is an approved medicine, and laboratory material is commonly labelled as not intended for human consumption. Anti-doping rules in sport list thymosin beta-4 and its fragments among prohibited peptide hormones. Because these products travel through research-chemical channels rather than pharmaceutical supply chains, quality varies considerably between vendors. Independent testing of identity, purity and sterility is the only dependable check, and a certificate of analysis describes one batch rather than a supplier's whole catalogue.
Lyophilized peptide powder is normally held desiccated at −20 °C, with −80 °C used for longer storage periods. Allowing a sealed vial to reach room temperature before opening is standard practice, because condensation forming on cold powder introduces moisture. Once dissolved, solutions are typically kept cold and shielded from light. Repeated freeze-thaw cycles are avoided because they encourage aggregation and gradual loss of material. These conventions are general to synthetic peptides rather than unique to any one sequence.
Identity and purity are assessed with a small set of standard techniques. Reverse-phase high-performance liquid chromatography gives a purity estimate from peak area, usually recorded at 214 or 220 nanometers, where the peptide bond absorbs. Mass spectrometry confirms the expected molecular mass and can reveal truncated or oxidized species. Amino acid analysis or tandem mass spectrometry sequencing can verify the sequence itself. Additional quality attributes include water content, residual trifluoroacetic acid carried over from purification, and endotoxin where the material is intended for biological work.
The compound is most often distributed as a lyophilized powder, appearing white to off-white and forming a loose cake or fluffy solid. It is hygroscopic to some degree, so brief exposure to humid air can add water weight and complicate weighing. The peptide dissolves readily in water and in neutral aqueous buffers, and aqueous solubility is generally described as high, well above the concentrations used in typical assays. Some polar organic solvents are also usable, which matters when a concentrated stock is prepared before dilution into buffer.
Storage recommendations center on keeping the dry powder cold, dry, and dark. A freezer at -20 degrees Celsius or below is conventional, and desiccant is often included to limit moisture uptake. Once dissolved, the peptide is less stable, and solutions are typically kept frozen and thawed only once. Repeated freeze-thaw cycles are a common source of losses because they promote aggregation and adsorption to container surfaces. Working aliquots are therefore prepared in advance, and glass or low-binding plastic is usually preferred over ordinary laboratory plastic.
Thymosin beta-4 itself is a natural peptide of 43 residues found in many cell types and body fluids. Its best-characterised function is binding and sequestering actin monomers, which influences cytoskeletal dynamics. The sequence most often associated with TB-500, LKKTETQ, corresponds to part of that actin-binding region. A different fragment, Ac-SDKP, is also derived from the same parent peptide and is studied in its own right, which is one reason discussions of thymosin fragments can become confusing. The two are structurally distinct and are not interchangeable.
Interest in the fragment grew during the 1990s and 2000s, when it moved from laboratory work into sports and supplement markets. Anti-doping bodies added thymosin beta-4 fragments to prohibited lists, and a small number of adverse analytical findings have been reported in competition testing. Published controlled human trials remain scarce. Most mechanistic evidence comes from cell culture and animal models, and those studies examine endpoints such as cell migration, wound closure and inflammation markers. That evidence supports research interest but does not establish clinical benefit, and broad regenerative claims should be read as unverified.
TB-500 is a short synthetic peptide sold under a trade name rather than a systematic chemical name. Suppliers usually describe it as a fragment of thymosin beta-4 and ship it as a lyophilised powder intended for laboratory use. Because the label is commercial, the exact sequence attributed to it is not fully consistent across catalogues, and some listings present a seven-residue peptide while others describe related fragments of similar length. It is not an approved medicine in any major jurisdiction, and it is handled as a research chemical.
== Experimental chemistry == Experimental results of the chemistry of dubnium date back to 1974 and 1976. JINR researchers used a thermochromatographic system and concluded that the volatility of dubnium bromide was less than that of niobium bromide and about the same as that of hafnium bromide. It is not certain that the detected fission products confirmed that the parent was indeed element 105. These results may imply that dubnium behaves more like hafnium than niobium. The next studies on the chemistry of dubnium were conducted in 1988, in Berkeley. They examined whether the most stable oxidation state of dubnium in aqueous solution was +5. Dubnium was fumed twice and washed with concentrated nitric acid; sorption of dubnium on glass cover slips was then compared with that of the group 5 elements niobium and tantalum and the group 4 elements zirconium and hafnium produced under similar conditions. The group 5 elements are known to sorb on glass surfaces; the group 4 elements do not. Dubnium was confirmed as a group 5 member. Surprisingly, the behavior on extraction from mixed nitric and hydrofluoric acid solution into methyl isobutyl ketone differed between dubnium, tantalum, and niobium. Dubnium did not extract and its behavior resembled niobium more closely than tantalum, indicating that complexing behavior could not be predicted purely from simple extrapolations of trends within a group in the periodic table. This prompted further exploration of the chemical behavior of complexes of dubnium.
As part of a comprehensive modernization of German radiation protection law, which is largely based on Directive 2013/59/Euratom, the provisions of the X-Ray Ordinance have been incorporated into the revised Radiation Protection Ordinance. Among many other measures, contaminated food was withdrawn from the market on a large scale. Parents were strongly advised not to let their children play in sandboxes. Some of the contaminated sand was replaced. In 1989, the Federal Office for Radiation Protection was incorporated into the Ministry of the Environment. On April 30, 2003, a new precautionary radiation protection law was promulgated to implement two EU directives on the health protection of persons against the dangers of ionizing radiation during medical exposure. The protection of workers from optical radiation (infrared radiation (IR), visible light (VIS) and ultraviolet radiation (UV)), which falls under the category of non-ionizing radiation, is regulated by the Ordinance on the Protection of Workers from Artificial Optical Radiation of 19 July 2010. It is based on the EU Directive 2006/25/EC of April 27, 2006. On March 1, 2010, the "Act on the Protection of Humans from Non-Ionizing Radiation" (NiSG), BGBl. I p. 2433, came into force, according to which the use of sunbeds by minors has been prohibited since August 4, 2009, in accordance with § 4 NiSG [Network and Information Systems Security Ordinance – NIS Ordinance] (in German) A new Radiation Protection Act came into force in Germany on October 1, 2017.
==== Non-seasonal depression ==== Light therapy has also been suggested in the treatment of non-seasonal depression and other psychiatric mood disturbances, including major depressive disorder, bipolar disorder and postpartum depression. A meta-analysis by the Cochrane Collaboration concluded that "for patients suffering from non-seasonal depression, light therapy offers modest though promising antidepressive efficacy." A 2008 systematic review concluded that "overall, bright light therapy is an excellent candidate for inclusion into the therapeutic inventory available for the treatment of nonseasonal depression today, as adjuvant therapy to antidepressant medication, or eventually as stand-alone treatment for specific subgroups of depressed patients." A 2015 review found that supporting evidence for light therapy was limited due to serious methodological flaws. A 2016 meta-analysis showed that bright light therapy appeared to be efficacious, particularly when administered for 2–5 weeks' duration and as monotherapy.
Elemental bromine (Br2) is toxic and causes chemical burns on human flesh. Inhaling bromine gas results in similar irritation of the respiratory tract, causing coughing, choking, shortness of breath, and death if inhaled in large enough amounts. Chronic exposure may lead to frequent bronchial infections and a general deterioration of health. As a strong oxidising agent, bromine is incompatible with most organic and inorganic compounds. Caution is required when transporting bromine; it is commonly carried in steel tanks lined with lead, supported by strong metal frames. The Occupational Safety and Health Administration (OSHA) of the United States has set a permissible exposure limit (PEL) for bromine at a time-weighted average (TWA) of 0.1 ppm. The National Institute for Occupational Safety and Health (NIOSH) has set a recommended exposure limit (REL) of TWA 0.1 ppm and a short-term limit of 0.3 ppm. The exposure to bromine immediately dangerous to life and health (IDLH) is 3 ppm. Bromine is classified as an extremely hazardous substance in the United States as defined in Section 302 of the U.S. Emergency Planning and Community Right-to-Know Act (42 U.S.C. 11002), and is subject to strict reporting requirements by facilities which produce, store, or use it in significant quantities.
(chaotropic) When oppositely charged kosmotropic cations and anions are in solution together, they are attracted to each other, rather than to water, and the same can be said for chaotropic cations and anions. Thus, the preferential associations of oppositely charged ions can be ordered as:
Sources: en.wikipedia.org
=== Terminology === Because of concerns around stigma, and because of a move away from the original theoretical basis for the term (see history), there is ongoing debate about renaming borderline personality disorder. While some clinicians agree with the current name, others argue that it should be changed, since many who are labelled with borderline personality disorder find the name unhelpful, stigmatizing, or inaccurate. Alternative suggestions for names include emotional regulation disorder or emotional dysregulation disorder. Impulse disorder and interpersonal regulatory disorder are other valid alternatives, according to John G. Gunderson of McLean Hospital in the United States. Another term suggested by psychiatrist Carolyn Quadrio is post-traumatic personality disorganization (PTPD), reflecting the condition's status as (often) both a form of chronic post-traumatic stress disorder (PTSD) as well as a personality disorder. However, although many with BPD do have traumatic histories, some do not report any traumatic event, which suggests that BPD is not necessarily a trauma spectrum disorder. The Treatment and Research Advancements National Association for Personality Disorders (TARA-APD) campaigned unsuccessfully to change the name and designation of BPD in DSM-5, published in May 2013, in which the name "borderline personality disorder" remains unchanged, and it is not considered a trauma- and stressor-related disorder.
During February 1945, the 4th Panzer Army defended along the Oder River, containing the Soviet bridgehead at Steinau on the Oder. In March and the first half of April 1945, the army concentrated on defenses along the Lusatian Neisse River between Görlitz and Guben. On April 16, 1945, the Red Army renewed its offensive by crossing the Oder River. While the 9th Army held the Soviet forces at the Battle of Seelow Heights, the 4th Panzer Army was being pushed back. V Corps of the retreating 4th Panzer Army was pushed into the operational region of the German 9th Army, forming a pocket of some 80,000 men. The Red Army then encircled this force in a pocket in the Spree Forest south of the Seelow Heights and west of Frankfurt. Some of the 4th Panzer Army troops trapped in the Halbe Pocket broke out to the west and surrendered to the US Army on the west bank of the Elbe River. The bulk of the 4th Panzer Army was pushed south of Dresden into the Ore Mountains where it surrendered to the Red Army in the wake of the early May 1945 Prague Offensive.
He was one of those vigorous, fearless thinkers who seem to be entirely free from the inhibitions which restrain most of us in narrow paths of scientific enquiry. ... His magnificent courage and imagination led him into every aspect of biology which presented problems to his consciousness. ... His originality of mind made him a stimulating colleague, and to his students he was as gracious as he was inspiring. ... Robertson's main service to science was in the realm of ideas. His practical work was of lesser significance, but in almost every direction in which his imagination led him he either contributed new conceptions or reoriented prevailing ideas." Hardolph Wasteneys, Professor of Biochemistry at the University of Toronto, The Biochemical Journal. A memorial collection of 12 Robertson items — comprised of ten of his previously published articles and the text of two of his speeches — with an introduction (SP.3) by his University of Adelaide colleague, Stuart Wortley Pennycuick (1887–1966) D.Sc., B.Sc., and edited by his wife (Jane Winifred Robertson), The Spirit of Research (BR.66), was published in 1931. On 5 September 1931, in the university's Animal Nutrition Building, Sir George Murray, the Chancellor of the University of Adelaide unveiled a bas-relief commemorative plaque (UA.3), designed and executed by Arthur Murch, that was dedicated to Robertson's memory.
Returning to Los Angeles, Parsons sought out Chris Hillman, and the two formed The Flying Burrito Brothers with bassist Chris Ethridge and pedal steel player Sneaky Pete Kleinow. Their 1969 album The Gilded Palace of Sin marked the culmination of Parsons' post-1966 musical vision: a modernized variant of the Bakersfield sound that was popularized by Buck Owens amalgamated with strands of soul and psychedelic rock. The band appeared on the album cover wearing Nudie suits emblazoned with hippie symbols, including marijuana, Tuinal, and Seconal-inspired patches. Along with the Parsons-Hillman originals "Christine's Tune" and "Sin City" were versions of the soul music classics "The Dark End of the Street" and "Do Right Woman, Do Right Man", the latter featuring David Crosby on high harmony. The original songs were the result of a productive songwriting partnership between Parsons and Hillman, who were sharing a bachelor pad in the San Fernando Valley. The pronounced gospel-soul influence on this album likely evolved from the ecumenical tastes of bassist Chris Ethridge, who co-wrote "Hot Burrito No. 1/I'm Your Toy" and "Hot Burrito No. 2" with Parsons. Original drummer Eddie Hoh was unable to perform adequate takes due to a substance abuse problem. He was dismissed after two songs and the band used session drummers, including former International Submarine Band drummer Jon Corneal and Popeye Phillips. Before commencing live performances, the group settled on original Byrds drummer Michael Clarke. The Gilded Palace of Sin was commercially unsuccessful.
== Commercial use == D-Ribose-L-cysteine is used as an ingredient in several commercially marketed dietary supplements, particularly products promoted for general antioxidant support and cellular health. The primary commercial producers and distributors include Max International, Inc. and LiveMax, LLC.
Sources: en.wikipedia.org
Pharmacology is often studied by focusing on specific systems, such as endogenous neurotransmitter systems. The major systems studied in pharmacology can be categorized by their ligands and their receptors which include, but are not limited to, acetylcholine (ACh), adenosine, adrenaline, anandamide, aspartate, glutamate, glycine, purines, substance P, eicosanoids, GABA, dopamine (DA), histamine, serotonin (5-HT), serine, cannabinoids, opioids, melatonin, vasopressin (ADH), and norepinephrine (NE). Molecular targets in pharmacology include receptors, enzymes, and membrane transport proteins. Enzymes can be targeted with enzyme inhibitors. Receptors are typically categorized based on structure and function. Major receptor types studied in pharmacology include G protein coupled receptors, ligand gated ion channels, and receptor tyrosine kinases. Network pharmacology is a subfield of pharmacology that combines principles from pharmacology, systems biology, and network analysis to study the complex interactions between drugs and targets (receptors or enzymes etc.) in biological systems. The topology of a biochemical reaction network determines the shape of drug dose-response curve as well as the type of drug-drug interactions, thus can help designing efficient and safe therapeutic strategies. The topology Network pharmacology utilizes computational tools and network analysis algorithms to identify drug targets, predict drug-drug interactions, elucidate signaling pathways, and explore the polypharmacology of drugs.
Although often prevented and treatable if detected early, pressure ulcers can be very difficult to prevent in critically ill people, frail elders, and individuals with impaired mobility such as wheelchair users (especially where spinal injury is involved). Primary prevention is to redistribute pressure by regularly turning the person. The benefit of turning to avoid further sores is well documented since at least the 19th century. In addition to turning and re-positioning the person in the bed or wheelchair, eating a balanced diet with adequate protein and keeping the skin free from exposure to urine and stool is important. The rate of pressure ulcers in hospital settings is high; the prevalence in European hospitals ranges from 8.3% to 23%, and the prevalence was 26% in Canadian healthcare settings from 1990 to 2003. In 2013, there were 29,000 documented deaths from pressure ulcers globally, up from 14,000 deaths in 1990. The United States has tracked rates of pressure injury since the early 2000s. Whittington and Briones reported nationwide rates of pressure injuries in hospitals of 6% to 8%. By the early 2010s, one study showed the rate of pressure injury had dropped to about 4.5% across the Medicare population following the introduction of the International Guideline for pressure injury prevention. Padula and colleagues have witnessed a +29% uptick in pressure injury rates in recent years associated with the rollout of penalizing Medicare policies.
The South Korean military called the missile tests "extremely inappropriate" in light of the pandemic. In February and March, U.S. officials observed a decrease in military activity in North Korea, which they believed to be a sign that there were COVID-19 cases in the country. General Robert B. Abrams observed that the North Korean military had "been on lockdown for about 30 days", and "didn't fly an airplane for 24 days". In mid-March, Kim Jong Un sent a letter to South Korean president Moon Jae-in as a show of support amidst the outbreak in South Korea. US President Donald Trump wrote a letter to Kim Jong Un to express his willingness to work with him on dealing with COVID-19. North Korean state media also reported on the severity of the outbreak in other countries. On 31 March, the Asia Times reported that North Korea's measures against the pandemic seemed largely successful.
The story and cast performances were positively received; Time Out magazine called it "flawed but impressive". Afterward, he starred in Rob Reiner's 2007 comedy The Bucket List opposite Jack Nicholson. The plot follows two terminally ill men on a road trip with a list of things to do before they die. The film grossed $175 million worldwide.
In October 2025, GSK announced it had acquired the rights to a prostate cancer drug developed by Syndivia, a French biotechnology company, for £268 million. In January 2026, GSK agreed to acquire Rapt Therapeutics in a deal valued at $2.2 billion. In January 2026, Alteogen Inc. entered into an exclusive license agreement with Tesaro, Inc., a subsidiary of GSK, allowing Tesaro to acquire world-wide rights to use ALT-B4, Alteogen's novel hyaluronidase utilising Hybrozyme technology, for the development and commercialisation of a subcutaneous formulation of dostarlimab, a programmed death receptor-1 (PD-1) blocking antibody. In February 2026, GlaxoSmithKline announced an agreement to acquire Canada-based biopharmaceutical firm 35Pharma for $950 million in cash. The deal includes the early-stage drug HS235 for pulmonary arterial hypertension and related conditions. In June 2026, GSK announced it was acquiring Nuvalent, an American biopharmaceutical company, for $10.6 billion. Subject to regulatory and shareholder approval, if complete, the deal will be its largest in more than 10 years.
Sources: en.wikipedia.org
TB-500 is a trade-style label for a synthetic peptide connected to thymosin beta-4. It is sold mainly through research-chemical channels and is not a single chemically defined product across suppliers.
Not necessarily. Some vendors use the name for the full 43-residue protein, while others apply it to a short actin-binding fragment or to a related tetrapeptide. The sequence should be confirmed from documentation rather than assumed from the label.
No thymosin beta-4 fragment holds marketing approval as a medicine in major jurisdictions. Material offered for sale is typically labelled for laboratory research only.
No. Thymosin beta-4 is a 43-residue protein, while TB-500 refers to a seven-residue fragment corresponding to its N-terminal region. The two names are often used loosely in commercial and community writing, which obscures the difference in size, sequence, and likely behavior.